SynthesisPLoS neglected tropical diseases2026
Human Filariasis in Africa (2000-2025): Changing epidemiology, uneven diagnostic progress, and persistent neglect.
Synthesis in PLoS neglected tropical diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHuman filariases remain a major group of neglected tropical diseases (NTDs) in Africa. Despite large-scale control strategies and availability of effective drugs, persistent and re-emerging infections indicate gaps in surveillance and diagnostic capacity. Over the past two decades, diagnostic technologies and elimination programs have evolved, yet no synthesis has assessed how these changes affected research output and prevalence estimates across the continent. The objective of this study was to systematically review and synthesize population-based studies on human filariases in Africa from 2000 to 2025, examining temporal trends, diagnostic methods, and prevalence patterns across species and regions.
methodsA systematic review compliant with PRISMA 2020 was conducted for studies published between January 2000 and October 2025 in PubMed, Scopus, ScienceDirect and African Index Medicus. We included population-based studies reporting prevalence of human filariases using confirmatory diagnostics. Data extraction included study characteristics, diagnostic method and prevalence estimate. Study quality was evaluated using the Newcastle-Ottawa Scale.
resultsA total of 180 studies from 31 African countries were included. Research activity peaked in 2011-2015 and then declined. Microscopy remained the dominant diagnostic method throughout the 25-year period, although serology and molecular tools increased after 2011. A consistent reduction in prevalence was observed for lymphatic filariasis and onchocerciasis in settings with mass drug administration (MDA). Mansonellosis and loiasis showed no comparable decline and were frequently detected incidentally, reflecting limited diagnostic oversight and the absence of targeted elimination programs.
conclusionsLong-term MDA programs are associated with reduced prevalence of lymphatic filariasis and onchocerciasis. Loiasis shows a increasing and unstable trend, influenced by diagnostic method and lack of targeted interventions. Mansonellosis remains neglected, underdiagnosed, and largely unmonitored. Strengthening local diagnostic capacity and integrating filariasis screening into existing platforms (e.g., malaria programs) may prevent silent transmission and resurgence in areas declared free of infection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.